Clinical Trials Directory

Trials / Completed

CompletedNCT00001254

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome

Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome

Status
Completed
Phase
Study type
Observational
Enrollment
273 (actual)
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This protocol concerns the approach to the localization, diagnosis of MEN1 and management of the tumor and the tissue samples in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor, investigations for MEN1 the subsequent management of the tumor and tissue samples for research.

Detailed description

This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.

Conditions

Timeline

Start date
1991-10-29
First posted
1999-11-04
Last updated
2026-03-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00001254. Inclusion in this directory is not an endorsement.

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome (NCT00001254) · Clinical Trials Directory